Gamma Investing LLC Blueprint Medicines Corp Transaction History
Gamma Investing LLC
- $734 Billion
- Q2 2024
A detailed history of Gamma Investing LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Gamma Investing LLC holds 186 shares of BPMC stock, worth $16,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
186
Previous 124
50.0%
Holding current value
$16,090
Previous $11.8 Million
70.42%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$575 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$566 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$508 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$280 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$213 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.17B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...